Tag: Lilly

Have interaction Bio developed a platform expertise that allows non-viral supply of DNA to cells. The acquisition is the newest ...

Wish to keep on prime of the science and politics driving biotech at this time? Join to get our biotech publication in ...

As competitors mounts within the red-hot marketplace for weight reduction medicine, France’s medicines regulator fined Novo Nordisk roughly $2 million ...

Eli Lilly is paying as much as $300 million for CrossBridge Bio, a startup growing antibody drug conjugates that ship ...

Alex Zhavoronkov, CEO of Insilico Drugs, can’t cease complimenting Eli Lilly. “Lilly is best in AI than Insilico, and no ...

Eli Lilly has been scouting for medication to comply with the path blazed by its blockbuster cardiometabolic medicines. Its newest ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...

Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...

WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s National Priority ...

A good Thursday to you all, with Andrew Joseph here in London filling in for Mr. Pharmalot. A busy August ...